HIV patients susceptible to psychosocial challenges like depression and anxiety, finds study

The agreement leverages Biovac’s expertise in vaccine development and manufacturing. Credit: Diana Polekhina on Unsplash. Sanofi and Biovac have announced a partnership to establish the

Xenon Phar­ma­ceu­ti­cals’ ma­jor de­pres­sive dis­or­der drug can­di­date didn’t reach sta­tis­ti­cal sig­nif­i­cance ver­sus place­bo in the pri­ma­ry end­point of a mid-stage tri­al, but the Cana­di­an biotech